Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Ferronordic’s investor presentation 11 May 2023

Ferronordic’s interim report for the first quarter 2023 will be published on 11 May 2023 at 07:30 CET. A presentation of the report will be held the same day at 10:00 CET.Ferronordic’s interim report for the first quarter 2023 will be published on 11 May 2023 at 07.30 CET and will be accessible at www.ferronordic.com. Ferronordic invites investors, analysts and the media to a presentation where Lars Corneliusson, CEO, and Erik Danemar, CFO, comment on the report. The presentation will be held on 11 May 2023 at 10:00 CET and can be followed via telephone conference or audiocast.   The

Carbiotix AB decides on preferential issue of units in order to, among other things, complete the GRAS SA process and accelerate sales activities. Company brings forward publication of the Q1-report

The board of Carbiotix AB ("Carbiotix" or the "Company") has today, 27 April 2023, with the support of an authorization from the annual general meeting, decided to carry out an issue of units consisting of shares and free warrants of series TO 2 ("TO 2"), with preferential rights for the Company's existing shareholders. The issue volume initially amounts to a maximum of approximately SEK 12 million before transaction costs (the "Rights Issue"). Upon full subscription of the Rights Issue and full utilization of issued TO 2 at the highest subscription price, the Company may receive an

HKScan publishes its January-March Interim Report on 10 May 2023

HKScan Corporation, media release 27 April 2023 at 1 p.m. EETHKScan Corporation publishes its January-March Interim Report on Wednesday 10 May 2023 at about 8.30 a.m. EET.  Investor calls will be arranged upon requests. Kindly contact executive assistant Marja Säkö, tel. +358 50 576 7130 or marja.sako@hkscan.com. HKScan Corporation Marja SiltalaSVP Communications  For further information:HKScan Media Service Desk, email communications@hkscan.com

Wärtsilä and the Maritime and Port Authority of Singapore to collaborate in accelerating maritime decarbonisation and digitalisation

Wärtsilä Corporation, Trade press release, 27 April 2023 at 1 PM EESTTechnology group Wärtsilä and the Maritime and Port Authority of Singapore (MPA) have signed a Memorandum of Understanding (MoU) aimed at collaborating in mutually beneficial areas to enable the introduction of next generation renewable fuels, optimise digital port operations, and develop future talent. Under the MoU, signed in April, MPA and Wärtsilä will explore renewable fuel technologies and seek partnerships with various stakeholders to develop green fuel safety concepts and procedures to ensure safe handling and

Invitation to press- and telephone conference regarding Skanska’s Interim report first quarter on May 4

Skanska’s Interim report first quarter 2023 will be released on Thursday, May 4 at 07:30 am CET. The report will be presented by Anders Danielsson, Skanska’s President and CEO, and Magnus Persson, CFO, at a press- and telephone conference at 10:00 am CET at Skanska’s head office at Warfvinges väg 25 in Stockholm. The press  conference will be webcasted live at www.skanska.com/investors, where it also will be posted shortly afterwards. To participate in the telephone conference, with the possibility to ask questions, please dial +46 (0)8 5051 0031; +44 (0) 207 107 06 13, or +1 (1) 631

Disposal of own shares based on the key management long-term incentive programme of Alma Media Corporation

Alma Media Corporation       Stock Exchange Release                    27 April 2023 at 1 p.m. DISPOSAL OF OWN SHARES BASED ON THE KEY MANAGEMENT LONG-TERM INCENTIVE PROGRAMME OF ALMA MEDIA CORPORATION A total of 168 877 of Alma Media Corporation's treasury shares are conveyed without consideration and according to the plan terms to the key management participating in the Matching Share Plan 2020. More details of this Long-Term incentive plan have been announced in a stock exchange release issued on 14 February 2020. The directed share issue is based on an authorization given by

Invitation to Tobii’s webcast following the interim report for the first quarter of 2023

Press release Stockholm, April 27, 2023 Tobii AB (publ) plans to publish the interim report for the period January 1 - March 31, 2023, on May 4 at 7.30 a.m. CET. Following this report, at 9.00 a.m. CET, Tobii will host a presentation for investors, analysts and media. Tobii’s President and CEO Anand Srivatsa and CFO Magdalena Rodell Andersson will present and comment on the report. After the presentation, there will be time for questions. The presentation will be held in English. Details · Time: Thursday May 4, 2023, 9.00 a.m. CET · Webcast: Link to the webcast 

Correction: Quickbit publishes Q3 interim report ‘22/23

Quickbit announces a correction to the press release published yesterday. The correction concerns reference to Significant uncertainty factor regarding Material Uncertainty Related to Going Concern in the auditor's review report. The following two paragraphs are added to the press release and are then followed by the original press release from yesterday.Reference to auditor’s review report The following is stated under the section Material Uncertainty Related to Going Concern: Without qualifying our review report, we draw attention to the Risk and uncertainties section on page 5 in the

UPM Plywood is planning to restructure its organization and scale its operations

(UPM Plywood, Lahti, 27 April 2023 at 13:00 EEST) – UPM Plywood is planning to restructure its organization and scale its operations to meet the reduced production capacity and the deteriorating market situation. The company will begin employee negotiations involving 262 salaried employees in the staff and global functions, in the sales offices and in the Finnish mills. It is estimated that the maximum reduction is 35 positions. Employee negotiations will be conducted in accordance with local legislation. “In the new situation, it is extremely important to renew the company's

Senior Lecturer awarded title of Biomedical Scientist of the Year

A Staffordshire University lecturer has won the title Biomedical Scientist of the Year for his pioneering work which includes the development and delivery of degree apprenticeships.Ian Davies, a Senior Lecturer in the School of Health, Science and Wellbeing, was announced as winner of the prestigious award at the Advancing Healthcare Awards  which celebrates the passion, dedication and innovation of allied health professionals. Ian is course leader for the Healthcare Science degree apprenticeship which

Skanska selected preferred bidder for the construction and O&M for the E10/rv. 85 road project in northern Norway

Skanska has as a part of a consortium been selected by the Norwegian Public Roads Administration (NPRA) as preferred bidder for the E10/rv. 85 Tjeldsund-Gullesfjordbotn-Langvassbukt road project in northern Norway. For Skanska, the scope of the project includes designing, building, and operating and maintaining the road for 15 years from completion.The project, that is being procured as a Public Private Partnership (PPP) by NPRA, is part of the transport link between Lofoten, Vesterålen Harstad/ Narvik Airport and the E6. It includes the construction and operation of 82 kilometers of new

Interim report January – March 2023

· Rental income increased 20 per cent to SEK 1,183 million (983). · Profit from property management increased 1 per cent to SEK 580 million (572). · Changes in the value of properties amounted to SEK -1,255 million (1,734) and changes in the value of financial instruments to SEK 103 million (-3). · Loss after tax for the period amounted to SEK -463 million (1,934). · The market value of the properties amounted to SEK 84,784 million (79,987). · During the period, SEK 649 million (942) was invested in the existing property portfolio. · During the period, 4 properties (17)

Record order intake, solid revenues and profitability

Nacka, Sweden, April 27, 2023: Mats Rahmström, President and CEO of the Atlas Copco Group, comments on the report for Q1 that was released today.“This was a very strong quarter,” said Mats Rahmström. ”Primarily due to several significant orders and strong project-related business, the order intake increased more than expected and reached a new record level.“ Order volumes for industrial compressors increased, driven by larger compressors. For gas and process compressors, the order growth was extraordinary. The demand for power equipment was strong, especially for portable compressors.

Metsä Group’s comparable operating result in January–March 2023 was EUR 276 million

Metsä Group Press release 27 April 2023Metsä Group Interim report January – March 2023 January–March 2023 (1–3/2022) · Sales were EUR 1.634 million (1.594). · Operating result was EUR 276 million (341). Comparable operating result was EUR 276 million (244). · Result before taxes was EUR 271 million (330). Comparable result before taxes was EUR 272 million (232). · Comparable return on capital employed was 15.3% (15.8). · Net cash flow from operations was EUR 38 million (135). Events during the first quarter of 2023 · The average sales prices for Metsä Group’s

Dicot's toxicology program successfully completed

Press release: Uppsala, April 27, 2023. Dicot announces today that the preclinical toxicology program required to start clinical phase 1 trial is completed. LIB-01 has shown a good safety profile in the toxicity studies.Dicot is developing a novel potency drug that aims to become the first choice of  treatment for erectile dysfunction and premature ejaculation. The company plans to start clinical studies with the drug candidate LIB-01 in mid-2023. Today the company announces that the preclinical toxicology program required for clinical phase 1 with LIB-01 has been completed. LIB-01 has

First-quarter report 2023

Record order intake, solid revenues and profitabilityThe comparison figures presented in this report refer to previous year unless otherwise stated.  First quarter · Orders received increased 18% to MSEK 47 707 (40 379), organic growth of 5% · Revenues increased 32% to MSEK 39 861 (30 086), organic growth of 18% · Operating profit reached MSEK 8 699 (6 749), corresponding to a margin of 21.8% (22.4) · Adjusted operating profit, excluding items affecting comparability, was MSEK 8 663 (6 525), corresponding to a margin of 21.7% (21.7) · Profit before tax amounted to

Metsä Board’s comparable operating result in January–March 2023 was EUR 89 million

Metsä Board Corporation Stock exchange release Interim Report 27 April 2023 at 12:00 noon EESTJanuary–March 2023 (compared to 1–3/2022) · Sales were EUR 542.1 million (582.0). · The comparable operating result was EUR 88.7 million 121.5), or 16.4% of sales (20.9). Operating result was EUR 88.4 million (140.7). · Comparable earnings per share were EUR 0.19 (0.26), and earnings per share were EUR 0.19 (0.31). · Comparable return on capital employed was 13.9 % (21.1). · Net cash flow from operations was EUR 126.4 million (92.6).   Events in January–March 2023 · The

Interim Report January-March 2023

AFRY starts the year with strong growth and EBITA development First quarter 2023 – Net sales increased by 22.0 percent to SEK 6,916 million (5,670) – Organic growth adjusted for calendar effects was 15.9 percent (3.3) – EBITA, excl. items affecting comparability, was SEK 689 million (472) – EBITA margin, excl. items affecting comparability, was 10.0 percent (8.3) – EBITA totalled SEK 689 million (359) – EBITA margin was 10.0 percent (6.3) – EBIT (operating profit) amounted to SEK 646 million (317) – Basic earnings per share: SEK 3.85 (1.97) COMMENTS BY THE CEO

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development

Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.The estimated cost for the project is EUR 14,6 million for two years, of which Business Finland will fund a maximum of 50% (EUR 7,3 million) in the form of a loan.  "The growing global market will need the expertise, advanced technologies, and digital solutions of Finnish companies and research organizations. Aiforia is a pioneer in its field

Södra delivers stable result in uncertain times

Södra posted a stable result for the first quarter of 2023. The result reflects the changed market conditions for Södra’s core products, while global turmoil is creating an uncertain outlook.In the first quarter of 2023, net sales for the Södra Group amounted to SEK 8,002 million (8,165), down 2 percent year-on-year. Operating profit totalled SEK 1,085 million (1,974), representing an operating margin of 14 percent (24). Return on capital employed was 19 percent (36) and the equity ratio increased to 68 percent. The first quarter result is an effect of expected and changed market

BioStock: Newly appointed CMO sees potential in Stayble Therapeutics

The Gothenburg-based pharmaceutical company Stayble Therapeutics recently announced Jarkko Kalliomäki as Chief Medical Officer of the company. He is an experienced pain physician and will contribute valuable expertise to the clinical development of the STA363 injection treatment, as well as in future partnership discussions. BioStock interviewed Jarkko Kalliomäki about his new role.Read the full article at biostock.se: https://www.biostock.se/en/2023/04/newly-appointed-cmo-sees-potential-in-stayble-therapeutics/ This is a press release from BioStock - Connecting Innovation & Capital.

BioStock: Article about CombiGene’s epilepsy project published in Gene Therapy

CombiGene recently achieved a milestone with the publication of a scientific article in Gene Therapy, a journal under the Nature Publishing Group. The paper presents the preclinical research findings of CombiGene’s epilepsy project CG01, which has been licensed to Spark Therapeutics.Read the article about CombiGene at biostock.se: https://www.biostock.se/en/2023/04/article-about-combigenes-epilepsy-project-published-in-gene-therapy/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Bulletin from Hemnet Group AB (publ)'s annual general meeting 2023

The annual general meeting of Hemnet Group AB (publ), held today Thursday 27 April 2023 in Stockholm, resolved in all parts in accordance with the board of directors' and the nomination committee's proposals to the annual general meeting. Adoption of balance sheets and income statements The annual general meeting approved the balance sheets and income statements of the parent company and the group for the financial year 2022.   DividendThe annual general meeting resolved on a dividend to the shareholders of SEK 1 per share for the financial year 2022. The annual general

There are no items matching the current filter
There are no more items matching the current filter
Back to top